N@N

Brad Canino Initiated (BPMC) at Hold and Held Target at $100 on, Mar 31st, 2021

Brad Canino of Credit Suisse, Initiated "Blueprint Medicines Corporation" (BPMC) at Hold and Held Target at $100 on, Mar 31st, 2021.

Brad has made no other calls on BPMC in the last 4 months.

There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 3 agree with Brad's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $105 on, Thursday, February 18th, 2021
• Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $95 on, Thursday, February 18th, 2021
• Konstantinos Aprilakis of "Stifel" Initiated at Hold and Held Target at $110 on, Thursday, December 3rd, 2020

This is the rating of the analyst that currently disagrees with Brad

---

• Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $127 on, Tuesday, January 12th, 2021